Granules India Limited (BSE: 532482, NSE: GRANULES) today announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. Senn develops and manufactures, Peptides and Peptides based applications for its global customers, providing contract research, development, and manufacturing services.
Dr. Parimala V Thirumalesh, Sr. Consultant - Neonatology & Pediatrics, Aster CMI Hospital, Bangalore As parents, ensuring that our children grow up healthy and strong is a top priority. One often overlooked but essential aspect of a child’s health is deworming. Intestinal worms are common among
Zydus Lifesciences Ltd. announced its unaudited consolidated financial results for the quarter and nine months ended December 31st, 2024. Key Financial Highlights Q3 FY25 Highlights Revenue from operations at Rs. 52,691 mn, up 17% over last year. Research & Development (R&D) investments for the quarter stood
Supporting Caregivers with Nutritious Meals & Financial Relief for Better Health and Well-being In a bustling city where hospitals brim with patients and their caregivers, the challenge of accessing healthy, affordable meals often compounds the emotional and logistical strain of caregiving. Recognizing this critical gap, Akshaya
Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received final approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine Dimesylate Capsules in strengths
by PRACHI CHANDRA, LEAD CLINICAL NUTRITIONIST, Sakra World Hospital Bengaluru A simple diet plan to lose weight can be made by focusing on balanced nutrition and creating a calorie deficit of minimum 500-600 kcal per day in order to lose 2-3 kg per month. Here's a simple
Dr Mahesh D M, Consultant Endocrinologist, Aster CMI Hospital Ozempic is currently one of the most popular drugs on the market, with many Hollywood as well as Bollywood celebs allegedly using it to lose weight. Recently on Christmas, Tesla and SpaceX CEO Elon Musk took to
The Indian pharmaceutical sector is strategically poised to capitalize on the recent healthcare initiatives introduced by President Donald Trump, aimed at enhancing the affordability and accessibility of medical treatments in the United States. This development presents significant opportunities for Indian drug manufacturers to expand their
Immuneel Therapeutics Launches Affordable CAR T-Cell Therapy for Blood Cancer in India Qartemi Offers New Hope for B-Cell Non-Hodgkin Lymphoma Patients at a Fraction of Global Costs Immuneel Therapeutics, a Bengaluru-based cell and gene therapy company co-founded by Kiran Mazumdar-Shaw, has announced the launch of Qartemi, India's
Chief Minister Bhajanlal Sharma has announced the development of the 'Apno Swasth Rajasthan' (Our Healthy Rajasthan) initiative, aiming to provide affordable, accessible, and high-quality medical facilities across the state. This strategic move underscores the government's commitment to enhancing healthcare services for all residents. Commitment to Affordable
